Cetera Trust Company N.A trimmed its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 55.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,050 shares of the financial services provider’s stock after selling 14,960 shares during the period. Cetera Trust Company N.A’s holdings in MetLife were worth $1,135,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of the company. CX Institutional grew its stake in shares of MetLife by 1.3% in the third quarter. CX Institutional now owns 8,672 shares of the financial services provider’s stock worth $817,000 after purchasing an additional 115 shares during the last quarter. Investment Research Partners LLC increased its holdings in MetLife by 3.9% during the 3rd quarter. Investment Research Partners LLC now owns 3,103 shares of the financial services provider’s stock valued at $292,000 after purchasing an additional 116 shares during the period. McGlone Suttner Wealth Management Inc. increased its holdings in MetLife by 0.6% during the 3rd quarter. McGlone Suttner Wealth Management Inc. now owns 22,391 shares of the financial services provider’s stock valued at $2,108,000 after purchasing an additional 124 shares during the period. International Private Wealth Advisors LLC increased its holdings in MetLife by 3.1% during the 3rd quarter. International Private Wealth Advisors LLC now owns 4,223 shares of the financial services provider’s stock valued at $398,000 after purchasing an additional 126 shares during the period. Finally, Capital Analysts LLC raised its position in MetLife by 0.3% during the 2nd quarter. Capital Analysts LLC now owns 38,262 shares of the financial services provider’s stock valued at $3,238,000 after purchasing an additional 129 shares during the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Trading Up 0.0%
NYSE:MET opened at $102.67 on Monday. The company has a 50-day moving average price of $98.75 and a 200-day moving average price of $86.90. The stock has a market cap of $64.52 billion, a price-to-earnings ratio of 13.39, a P/E/G ratio of 0.97 and a beta of 0.79. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.65. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $106.72.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.77 by $0.01. MetLife had a net margin of 6.21% and a return on equity of 25.71%. The company had revenue of $20.52 billion for the quarter, compared to analysts’ expectations of $19.86 billion. During the same quarter in the previous year, the company earned $2.34 earnings per share. MetLife’s quarterly revenue was up 18.2% on a year-over-year basis. Equities analysts predict that MetLife, Inc. will post 9.91 EPS for the current year.
MetLife declared that its board has approved a share buyback plan on Wednesday, August 5th that permits the company to repurchase $3 billion in outstanding shares. This repurchase authorization permits the financial services provider to buy up to 4.8% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Shareholders of record on Tuesday, November 3rd will be issued a $0.5925 dividend. The ex-dividend date is Tuesday, November 3rd. This represents a $2.37 annualized dividend and a yield of 2.3%. MetLife’s dividend payout ratio (DPR) is 30.90%.
Insiders Place Their Bets
In other MetLife news, CEO Michel Khalaf sold 187,425 shares of MetLife stock in a transaction that occurred on Tuesday, November 10th. The stock was sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the sale, the chief executive officer directly owned 759,013 shares of the company’s stock, valued at approximately $78,155,568.61. The trade was a 19.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.40% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on MET. Weiss Ratings upgraded MetLife from a “buy (b)” rating to a “buy (b+)” rating in a report on Monday, November 9th. Keefe, Bruyette & Woods lifted their price objective on MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 11th. Barclays boosted their target price on MetLife from $97.00 to $111.00 and gave the company an “overweight” rating in a research note on Wednesday, October 7th. Argus upped their target price on MetLife from $93.00 to $109.00 and gave the company a “buy” rating in a report on Wednesday, September 2nd. Finally, Wells Fargo & Company upped their target price on MetLife from $110.00 to $113.00 and gave the company an “overweight” rating in a report on Thursday. Fourteen analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, MetLife presently has an average rating of “Moderate Buy” and a consensus target price of $107.12.
Latest MetLife News
Here’s some of the latest news about MET:
- Positive Sentiment: Analysts raised their price targets. Mizuho lifted its target to $117 from $112 and maintained an “outperform” rating; Wells Fargo raised its target to $113 from $110 and kept an “overweight” rating. The higher targets indicate continued analyst confidence and potential upside. Mizuho price target article Wells Fargo price target article
- Neutral Sentiment: MetLife earned workplace recognition. The company was named among the 2026 Fortune World’s Best Workplaces and topped U.S.-based financial services and insurance companies on the list. This may support its reputation as an employer, though the direct impact on near-term earnings is unclear. Fortune workplace ranking article
- Negative Sentiment: CEO Michel Khalaf sold 187,425 shares for about $19.3 million, reducing his position by 19.8%. Insider sales can concern investors, although Khalaf retained 759,013 shares after the transaction. CEO share sale article
About MetLife
MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.
Further Reading
- Five stocks we like better than MetLife
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
